GO:0006270 | DNA replication initiation | 3.55% (7/197) | 6.09 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 12.69% (25/197) | 1.72 | 0.0 | 2.6e-05 |
GO:1901360 | organic cyclic compound metabolic process | 12.69% (25/197) | 1.69 | 0.0 | 2.8e-05 |
GO:0046483 | heterocycle metabolic process | 12.69% (25/197) | 1.73 | 0.0 | 3.7e-05 |
GO:0006139 | nucleobase-containing compound metabolic process | 11.68% (23/197) | 1.71 | 1e-06 | 5.5e-05 |
GO:0043227 | membrane-bounded organelle | 5.08% (10/197) | 2.56 | 8e-06 | 0.000488 |
GO:0043231 | intracellular membrane-bounded organelle | 5.08% (10/197) | 2.56 | 8e-06 | 0.000488 |
GO:0034641 | cellular nitrogen compound metabolic process | 12.69% (25/197) | 1.43 | 6e-06 | 0.000517 |
GO:0005634 | nucleus | 4.57% (9/197) | 2.69 | 1.1e-05 | 0.000579 |
GO:0090304 | nucleic acid metabolic process | 9.14% (18/197) | 1.62 | 2.5e-05 | 0.001177 |
GO:0006807 | nitrogen compound metabolic process | 17.77% (35/197) | 1.04 | 3.1e-05 | 0.00135 |
GO:0003677 | DNA binding | 7.11% (14/197) | 1.81 | 5.2e-05 | 0.001388 |
GO:0016874 | ligase activity | 3.55% (7/197) | 2.94 | 3.5e-05 | 0.001411 |
GO:0005524 | ATP binding | 11.68% (23/197) | 1.32 | 5.1e-05 | 0.001439 |
GO:0097159 | organic cyclic compound binding | 19.8% (39/197) | 0.94 | 5e-05 | 0.001509 |
GO:1901363 | heterocyclic compound binding | 19.8% (39/197) | 0.94 | 5e-05 | 0.001509 |
GO:0030554 | adenyl nucleotide binding | 11.68% (23/197) | 1.3 | 6.4e-05 | 0.00153 |
GO:0032559 | adenyl ribonucleotide binding | 11.68% (23/197) | 1.3 | 6.2e-05 | 0.001552 |
GO:0006259 | DNA metabolic process | 6.09% (12/197) | 2.01 | 4.7e-05 | 0.001602 |
GO:0008144 | drug binding | 12.18% (24/197) | 1.29 | 4.6e-05 | 0.001683 |
GO:0036094 | small molecule binding | 13.71% (27/197) | 1.11 | 0.000127 | 0.002892 |
GO:0044281 | small molecule metabolic process | 5.58% (11/197) | 1.94 | 0.000154 | 0.003343 |
GO:0009987 | cellular process | 20.3% (40/197) | 0.84 | 0.00017 | 0.003543 |
GO:0003674 | molecular_function | 42.13% (83/197) | 0.49 | 0.000207 | 0.004124 |
GO:0003676 | nucleic acid binding | 11.17% (22/197) | 1.21 | 0.000223 | 0.004266 |
GO:0035639 | purine ribonucleoside triphosphate binding | 11.68% (23/197) | 1.15 | 0.000294 | 0.005219 |
GO:0008152 | metabolic process | 23.35% (46/197) | 0.73 | 0.000287 | 0.005295 |
GO:0044427 | chromosomal part | 2.54% (5/197) | 3.02 | 0.000368 | 0.005503 |
GO:0000166 | nucleotide binding | 12.69% (25/197) | 1.07 | 0.000348 | 0.00555 |
GO:1901265 | nucleoside phosphate binding | 12.69% (25/197) | 1.07 | 0.000348 | 0.00555 |
GO:0017076 | purine nucleotide binding | 11.68% (23/197) | 1.13 | 0.000365 | 0.005638 |
GO:0043168 | anion binding | 12.69% (25/197) | 1.06 | 0.000401 | 0.005643 |
GO:0071704 | organic substance metabolic process | 18.78% (37/197) | 0.83 | 0.000391 | 0.005677 |
GO:0032553 | ribonucleotide binding | 11.68% (23/197) | 1.11 | 0.000418 | 0.00572 |
GO:0032555 | purine ribonucleotide binding | 11.68% (23/197) | 1.13 | 0.000343 | 0.005873 |
GO:0005488 | binding | 27.41% (54/197) | 0.63 | 0.000456 | 0.006071 |
GO:0097367 | carbohydrate derivative binding | 11.68% (23/197) | 1.1 | 0.000471 | 0.006093 |
GO:0051726 | regulation of cell cycle | 1.52% (3/197) | 4.23 | 0.000484 | 0.0061 |
GO:0044283 | small molecule biosynthetic process | 3.05% (6/197) | 2.55 | 0.000572 | 0.007024 |
GO:0044238 | primary metabolic process | 17.77% (35/197) | 0.82 | 0.000654 | 0.007826 |
GO:0008150 | biological_process | 29.44% (58/197) | 0.58 | 0.000691 | 0.008068 |
GO:0019752 | carboxylic acid metabolic process | 3.55% (7/197) | 2.14 | 0.00108 | 0.012321 |
GO:0044237 | cellular metabolic process | 16.24% (32/197) | 0.82 | 0.00113 | 0.012589 |
GO:0019438 | aromatic compound biosynthetic process | 4.06% (8/197) | 1.95 | 0.001167 | 0.012708 |
GO:0043436 | oxoacid metabolic process | 3.55% (7/197) | 2.1 | 0.001274 | 0.013562 |
GO:0006082 | organic acid metabolic process | 3.55% (7/197) | 2.09 | 0.001326 | 0.013813 |
GO:0018130 | heterocycle biosynthetic process | 4.06% (8/197) | 1.9 | 0.001436 | 0.014631 |
GO:0043170 | macromolecule metabolic process | 13.71% (27/197) | 0.88 | 0.001471 | 0.01468 |
GO:0006732 | coenzyme metabolic process | 2.03% (4/197) | 3.0 | 0.001556 | 0.014909 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.03% (4/197) | 3.0 | 0.001556 | 0.014909 |
GO:0009117 | nucleotide metabolic process | 2.54% (5/197) | 2.53 | 0.001755 | 0.016484 |
GO:0006753 | nucleoside phosphate metabolic process | 2.54% (5/197) | 2.49 | 0.001969 | 0.01814 |
GO:1901362 | organic cyclic compound biosynthetic process | 4.06% (8/197) | 1.81 | 0.002118 | 0.019143 |
GO:0046496 | nicotinamide nucleotide metabolic process | 1.52% (3/197) | 3.46 | 0.002474 | 0.02155 |
GO:0019362 | pyridine nucleotide metabolic process | 1.52% (3/197) | 3.46 | 0.002474 | 0.02155 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 1.52% (3/197) | 3.4 | 0.002788 | 0.023433 |
GO:0072524 | pyridine-containing compound metabolic process | 1.52% (3/197) | 3.4 | 0.002788 | 0.023433 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 2.03% (4/197) | 2.73 | 0.0031 | 0.02475 |
GO:0043226 | organelle | 5.08% (10/197) | 1.49 | 0.003154 | 0.024769 |
GO:0043229 | intracellular organelle | 5.08% (10/197) | 1.5 | 0.003083 | 0.02503 |
GO:0009058 | biosynthetic process | 7.61% (15/197) | 1.16 | 0.003043 | 0.025128 |
GO:0140101 | catalytic activity, acting on a tRNA | 2.03% (4/197) | 2.7 | 0.003319 | 0.025641 |
GO:0034404 | nucleobase-containing small molecule biosynthetic process | 1.52% (3/197) | 3.29 | 0.003487 | 0.026101 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 1.02% (2/197) | 4.46 | 0.00346 | 0.026305 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.54% (5/197) | 2.29 | 0.003674 | 0.026666 |
GO:0003824 | catalytic activity | 23.35% (46/197) | 0.56 | 0.003641 | 0.02683 |
GO:0019693 | ribose phosphate metabolic process | 2.03% (4/197) | 2.65 | 0.003787 | 0.027075 |
GO:0072527 | pyrimidine-containing compound metabolic process | 1.02% (2/197) | 4.29 | 0.004415 | 0.031099 |
GO:0009165 | nucleotide biosynthetic process | 2.03% (4/197) | 2.55 | 0.004854 | 0.033215 |
GO:1901293 | nucleoside phosphate biosynthetic process | 2.03% (4/197) | 2.55 | 0.004854 | 0.033215 |
GO:0044424 | intracellular part | 8.12% (16/197) | 1.02 | 0.00585 | 0.038388 |
GO:0046394 | carboxylic acid biosynthetic process | 2.03% (4/197) | 2.48 | 0.005775 | 0.038419 |
GO:0016053 | organic acid biosynthetic process | 2.03% (4/197) | 2.48 | 0.005775 | 0.038419 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 3.05% (6/197) | 1.87 | 0.006181 | 0.040011 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.52% (3/197) | 2.95 | 0.00673 | 0.041331 |
GO:0050790 | regulation of catalytic activity | 1.02% (2/197) | 4.0 | 0.006645 | 0.041334 |
GO:0065009 | regulation of molecular function | 1.02% (2/197) | 4.0 | 0.006645 | 0.041334 |
GO:0048523 | negative regulation of cellular process | 1.02% (2/197) | 4.0 | 0.006645 | 0.041334 |
GO:1901564 | organonitrogen compound metabolic process | 10.15% (20/197) | 0.85 | 0.00789 | 0.047842 |
GO:0006177 | GMP biosynthetic process | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0006098 | pentose-phosphate shunt | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0046653 | tetrahydrofolate metabolic process | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0042555 | MCM complex | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0051095 | regulation of helicase activity | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0051097 | negative regulation of helicase activity | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:1905462 | regulation of DNA duplex unwinding | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:1905463 | negative regulation of DNA duplex unwinding | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:1905774 | regulation of DNA helicase activity | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:1905775 | negative regulation of DNA helicase activity | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0004820 | glycine-tRNA ligase activity | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0006426 | glycyl-tRNA aminoacylation | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0004764 | shikimate 3-dehydrogenase (NADP+) activity | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0003855 | 3-dehydroquinate dehydratase activity | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0046654 | tetrahydrofolate biosynthetic process | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0003883 | CTP synthase activity | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0004146 | dihydrofolate reductase activity | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0003922 | GMP synthase (glutamine-hydrolyzing) activity | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0051156 | glucose 6-phosphate metabolic process | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:1901070 | guanosine-containing compound biosynthetic process | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0046037 | GMP metabolic process | 0.51% (1/197) | 6.46 | 0.011399 | 0.048317 |
GO:0043038 | amino acid activation | 1.52% (3/197) | 2.83 | 0.008524 | 0.048607 |
GO:0043039 | tRNA aminoacylation | 1.52% (3/197) | 2.83 | 0.008524 | 0.048607 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 1.52% (3/197) | 2.83 | 0.008524 | 0.048607 |
GO:0004812 | aminoacyl-tRNA ligase activity | 1.52% (3/197) | 2.83 | 0.008524 | 0.048607 |
GO:0046390 | ribose phosphate biosynthetic process | 1.52% (3/197) | 2.65 | 0.012082 | 0.048635 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 1.52% (3/197) | 2.65 | 0.012082 | 0.048635 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.52% (3/197) | 2.65 | 0.012082 | 0.048635 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.52% (3/197) | 2.65 | 0.012082 | 0.048635 |
GO:0009260 | ribonucleotide biosynthetic process | 1.52% (3/197) | 2.65 | 0.012082 | 0.048635 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.52% (3/197) | 2.65 | 0.012082 | 0.048635 |